跳至主要内容
临床试验/NCT04829994
NCT04829994进行中(未招募)不适用

A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT EXACT® Continence System for the Treatment of Stress Urinary Incontinence

Ethicon, Inc.13 个研究点 分布在 6 个国家目标入组 198 人开始时间: 2021年7月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Ethicon, Inc.
入组人数
198
试验地点
13
主要终点
Cough Stress Test (CST) Assessment Change

研究概览

简要总结

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retropubic mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects who satisfy all of the following criteria will be considered eligible for enrollment in this study:
  • Stress urinary incontinence symptoms
  • Stress urinary incontinence confirmed by diagnostic evaluation of a cough stress test
  • Female subjects ≥ 21 years of age requiring treatment of SUI
  • Desired surgical correction of stress urinary incontinence using a synthetic pubo-urethral vaginal sling
  • Planned surgery for primary stress incontinence without concomitant prolapse surgery
  • Patient able and willing to participate in follow-up
  • Subject or authorized representative has signed the approved informed consent

排除标准

  • Subjects meeting any of the following criteria will be considered not eligible for enrollment in this study:
  • Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits and are unable to complete the questionnaires
  • Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product
  • History of previous synthetic, biologic or fascial pubo-urethral sling
  • Pregnancy or plans for future pregnancy
  • History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice.
  • Current genitourinary fistula or urethral diverticulum
  • Reversible cause of incontinence (i.e. drug effect)
  • Contraindication to surgery

结局指标

主要结局

Cough Stress Test (CST) Assessment Change

时间窗: Post-surgery through study completion, approximately 5-10 yrs

Objective cure of Stress Urinary Incontinence (SUI) (treatment success) sproximately 5-10 years after surgery, defined as a negative CST

次要结局

  • Patient Global Impression of Improvement (PGI-I)(Post-surgery through study completion, approximately 10 yrs)
  • International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)(Baseline and post-surgery through study completion, approximately 10 yrs)
  • Wong-Baker FACES® Pain Rating Scale(Post-surgery through study completion, approximately 10 yrs)
  • Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)(Baseline and post-surgery through study, approximately 10 yrs completion)

研究者

发起方
Ethicon, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验

Post-Market Clinical Follow-Up onTVT EXACT®... | 临床试验